The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/

The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/–/ApoE–/– mice

Published:2012-03 Issue:5 Volume:52 Page:841-849
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Mercer John R.,Yu Emma,Figg Nichola,Cheng Kian-Kai,Prime Tracy A.,Griffin Julian L.,Masoodi Mojgan,Vidal-Puig Antonio,Murphy Michael P.,Bennett Martin R.

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference19 articles.

1. The developmental origins, mechanisms, and implications of metabolic syndrome;Bruce;J. Nutr.,2010

2. Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome?;Nisoli;Circ. Res.,2007

3. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease;Ren;J. Mol. Med.,2010

4. Regulation of mitochondrial biogenesis in metabolic syndrome;Rolo;Curr. Drug Targets,2011

5. Mitochondrial dysfunction in cardiovascular disease;Ballinger;Free Radic. Biol. Med.,2005

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities;European Journal of Medicinal Chemistry;2024-11

2. Metformin: From diabetes to cancer to prolongation of life;Pharmacological Research;2024-10

3. Oxidative stress and vascular dysfunction: Potential therapeutic targets and therapies in peripheral artery disease;Microvascular Research;2024-09

4. DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application;International Journal of Molecular Sciences;2024-08-21

5. Mitochondrial dysfunction and metabolic syndrome;Metabolic Syndrome;2024